237 related articles for article (PubMed ID: 36814822)
1. Myeloid leukemia factor 1: A "double-edged sword" in health and disease.
Li Z; Yang Y; Wu K; Li Y; Shi M
Front Oncol; 2023; 13():1124978. PubMed ID: 36814822
[TBL] [Abstract][Full Text] [Related]
2. Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation.
Yoneda-Kato N; Kato JY
Mol Cell Biol; 2008 Jan; 28(1):422-34. PubMed ID: 17967869
[TBL] [Abstract][Full Text] [Related]
3. Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia.
Nakamae I; Kato JY; Yokoyama T; Ito H; Yoneda-Kato N
Blood Adv; 2017 Sep; 1(20):1682-1693. PubMed ID: 29296815
[TBL] [Abstract][Full Text] [Related]
4. Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3.
Sun Y; Fu A; Xu W; Chao JR; Moshiach S; Morris SW
J Physiol Biochem; 2015 Dec; 71(4):807-21. PubMed ID: 26563351
[TBL] [Abstract][Full Text] [Related]
5. Myeloid leukemia factor 1 associates with a novel heterogeneous nuclear ribonucleoprotein U-like molecule.
Winteringham LN; Endersby R; Kobelke S; McCulloch RK; Williams JH; Stillitano J; Cornwall SM; Ingley E; Klinken SP
J Biol Chem; 2006 Dec; 281(50):38791-800. PubMed ID: 17008314
[TBL] [Abstract][Full Text] [Related]
6. MADM, a novel adaptor protein that mediates phosphorylation of the 14-3-3 binding site of myeloid leukemia factor 1.
Lim R; Winteringham LN; Williams JH; McCulloch RK; Ingley E; Tiao JY; Lalonde JP; Tsai S; Tilbrook PA; Sun Y; Wu X; Morris SW; Klinken SP
J Biol Chem; 2002 Oct; 277(43):40997-1008. PubMed ID: 12176995
[TBL] [Abstract][Full Text] [Related]
7. Myeloid Leukemia Factor 1 inhibits erythropoietin-induced differentiation, cell cycle exit and p27Kip1 accumulation.
Winteringham LN; Kobelke S; Williams JH; Ingley E; Klinken SP
Oncogene; 2004 Jun; 23(29):5105-9. PubMed ID: 15122318
[TBL] [Abstract][Full Text] [Related]
8. Subcellular localization of full-length human myeloid leukemia factor 1 (MLF1) is independent of 14-3-3 proteins.
Molzan M; Ottmann C
Cell Mol Biol Lett; 2013 Mar; 18(1):137-48. PubMed ID: 23271436
[TBL] [Abstract][Full Text] [Related]
9. Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3.
Yoneda-Kato N; Tomoda K; Umehara M; Arata Y; Kato JY
EMBO J; 2005 May; 24(9):1739-49. PubMed ID: 15861129
[TBL] [Abstract][Full Text] [Related]
10. cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia.
Hitzler JK; Witte DP; Jenkins NA; Copeland NG; Gilbert DJ; Naeve CW; Look AT; Morris SW
Am J Pathol; 1999 Jul; 155(1):53-9. PubMed ID: 10393836
[TBL] [Abstract][Full Text] [Related]
11. NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes.
Darracq A; Pak H; Bourgoin V; Zmiri F; Dellaire G; Affar EB; Milot E
PLoS Genet; 2019 Nov; 15(11):e1008463. PubMed ID: 31675375
[TBL] [Abstract][Full Text] [Related]
12. MLF1 is a proapoptotic antagonist of HOP complex-mediated survival.
Sun Y; Chao JR; Xu W; Pourpak A; Boyd K; Moshiach S; Qi GY; Fu A; Shao HR; Pounds S; Morris SW
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):719-727. PubMed ID: 28137643
[TBL] [Abstract][Full Text] [Related]
13. Myeloid leukemia factor-1 is a novel modulator of neonatal rat cardiomyocyte proliferation.
Rangrez AY; Pott J; Kluge A; Frauen R; Stiebeling K; Hoppe P; Sossalla S; Frey N; Frank D
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):634-644. PubMed ID: 28087342
[TBL] [Abstract][Full Text] [Related]
14. CRL4
Huang D; Liu C; Sun X; Sun X; Qu Y; Tang Y; Li G; Tong T
Biochem Biophys Res Commun; 2020 Aug; 529(2):127-132. PubMed ID: 32703400
[TBL] [Abstract][Full Text] [Related]
15. Investigation of tissue-specific expression and functions of MLF1-IP during development and in the immune system.
Wang X; Marcinkiewicz M; Gatain Y; Bouchard M; Mao J; Tremblay M; Uetani N; Hanissian S; Qi S; Wu J; Luo H
PLoS One; 2013; 8(5):e63783. PubMed ID: 23724000
[TBL] [Abstract][Full Text] [Related]
16. MLF1 protein is a potential therapy target for lung adenocarcinoma.
Li X; Min S; Wang H; Shen Y; Li W; Chen Y; Wang X
Int J Clin Exp Pathol; 2018; 11(7):3533-3541. PubMed ID: 31949731
[TBL] [Abstract][Full Text] [Related]
17. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.
Yoneda-Kato N; Look AT; Kirstein MN; Valentine MB; Raimondi SC; Cohen KJ; Carroll AJ; Morris SW
Oncogene; 1996 Jan; 12(2):265-75. PubMed ID: 8570204
[TBL] [Abstract][Full Text] [Related]
18. An update on the role of tumor necrosis factor alpha stimulating gene-6 in inflammatory diseases.
Li R; Ji C; Dai M; Huang J; Xu W; Ma Y; Zhang H
Mol Immunol; 2022 Dec; 152():224-231. PubMed ID: 36379130
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced by the myelodysplastic syndrome-associated NPM-MLF1 chimeric protein.
Yoneda-Kato N; Fukuhara S; Kato J
Oncogene; 1999 Jun; 18(25):3716-24. PubMed ID: 10391679
[TBL] [Abstract][Full Text] [Related]
20. Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome.
Matsumoto N; Yoneda-Kato N; Iguchi T; Kishimoto Y; Kyo T; Sawada H; Tatsumi E; Fukuhara S
Leukemia; 2000 Oct; 14(10):1757-65. PubMed ID: 11021751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
